Zimbabwe faces LCIA claim over covid-19 testing kits
Zimbabwe’s state-owned pharmaceutical company has been threatened with an LCIA claim over the termination of a US$60 million contract to supply covid-19 testing kits, amid a criminal investigation that has led to charges against the country’s former health minister.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.